„Multicenter, randomized, placebo-controlled, double-blind, parallel group, dose-finding Phase 2 study to evaluate efficacy and safety of BAY 2433334 in patients following an acute noncardioembolic ischemic stroke“

Bayer feasibility BAY 2433334 / 19776

firefleye – A randomized, 2-arm, open-label, phase 3 study to evaluate the efficacy, safety, and tolerability of intravitreal aflibercept versus laser photocoagulation in subjects with retinopathy of prematurity

firefleye next – An extension study to evaluate the long-term outcomes of subjects who received treatment for retinopathy of prematurity in Study 20090

OCEANIC Stroke